Cargando…

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management

Type 2 diabetes is one of the most relevant risk factors for heart failure, the prevalence of which is increasing worldwide. The aim of the review is to highlight the current perspectives of the pathophysiology of heart failure as it pertains to type 2 diabetes. This review summarizes the proposed m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ceriello, Antonio, Catrinoiu, Doina, Chandramouli, Chanchal, Cosentino, Francesco, Dombrowsky, Annique Cornelia, Itzhak, Baruch, Lalic, Nebojsa Malić, Prattichizzo, Francesco, Schnell, Oliver, Seferović, Petar M., Valensi, Paul, Standl, Eberhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571004/ https://www.ncbi.nlm.nih.gov/pubmed/34740359 http://dx.doi.org/10.1186/s12933-021-01408-1

Ejemplares similares

Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2019)

Issues for the management of people with diabetes and COVID-19 in ICU
por: Ceriello, Antonio, et al.
Publicado: (2020)

Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2016)

Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2018)

Correction to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2017)

Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2017)

Report from the 5th cardiovascular outcome trial (CVOT) summit
por: Schnell, Oliver, et al.
Publicado: (2020)

Comparison of mechanisms and transferability of outcomes of SGLT2 inhibition between type 1 and type 2 diabetes
por: Schnell, Oliver, et al.
Publicado: (2020)

Type 1 diabetes and cardiovascular disease
por: Schnell, Oliver, et al.
Publicado: (2013)

Postprandial Hyperglycemia and Glycemic Variability: Should we care?
por: Standl, Eberhard, et al.
Publicado: (2011)

Heart failure outcomes and Covid-19
por: Standl, Eberhard, et al.
Publicado: (2021)

Current perspectives on cardiovascular outcome trials in diabetes
por: Schnell, Oliver, et al.
Publicado: (2016)

Correction to: Updates on cardiovascular outcome trials in diabetes
por: Schnell, Oliver, et al.
Publicado: (2017)

Updates on cardiovascular outcome trials in diabetes
por: Schnell, Oliver, et al.
Publicado: (2017)

Contrast-induced nephropathy in a patient with type 2 diabetes and coronary artery disease: a case report
por: Seferovic, Jelena P., et al.
Publicado: (2021)

Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop
por: Ceriello, Antonio, et al.
Publicado: (2023)

Pharmacological management of COVID-19 in type 2 diabetes
por: Ceriello, Antonio, et al.
Publicado: (2021)

Variability of risk factors and diabetes complications
por: Ceriello, Antonio, et al.
Publicado: (2021)

Report from the CVOT Summit 2020: new cardiovascular and renal outcomes
por: Schnell, Oliver, et al.
Publicado: (2021)

The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice
por: Schnell, Oliver, et al.
Publicado: (2009)

Glycemic Control: A Combination of Lifestyle Management and the Use of Drugs
por: Standl, Eberhard, et al.
Publicado: (2012)

Defending the Con Side: Obesity Paradox Does Not Exist
por: Standl, Eberhard, et al.
Publicado: (2013)

Chronic Diabetic Complications: Current Challenges and Opportunities
por: Migdalis, Ilias N., et al.
Publicado: (2022)

Non‐insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials
por: Savarese, Gianluigi, et al.
Publicado: (2020)

Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes
por: Schnell, Oliver, et al.
Publicado: (2022)

Increased left ventricular mass index is present in patients with type 2 diabetes without ischemic heart disease
por: Seferovic, Jelena P., et al.
Publicado: (2018)

DPP-4 Inhibitors Have Different Effects on Endothelial Low-Grade Inflammation and on the M1-M2 Macrophage Polarization Under Hyperglycemic Conditions
por: De Nigris, Valeria, et al.
Publicado: (2021)

Heart Failure and Multimorbidity in Asia
por: Ang, Nathalie, et al.
Publicado: (2023)

Introduction to the special issue entitled ‘Heart failure management of the elderly patient: focus on frailty, sarcopenia, cachexia, and dementia’
por: Seferović, Petar M
Publicado: (2019)

Tackling the pillars of ageing to fight COVID-19
por: Prattichizzo, Francesco, et al.
Publicado: (2021)

Heart Failure and Importance of Collaboration of Professional Organizations: The Role of the Heart Failure Association of the European Society of Cardiology and Its Committee on National Heart Failure Societies
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2015)

On the potential of acarbose to reduce cardiovascular disease
por: Standl, Eberhard, et al.
Publicado: (2014)

Hypertension in Obese Type 2 Diabetes Patients is Associated with Increases in Insulin Resistance and IL-6 Cytokine Levels: Potential Targets for an Efficient Preventive Intervention
por: Lukic, Ljiljana, et al.
Publicado: (2014)

Glucose-sensing microRNA-21 disrupts ROS homeostasis and impairs antioxidant responses in cellular glucose variability
por: La Sala, Lucia, et al.
Publicado: (2018)

One-hour plasma glucose combined with skin autofluorescence identifies subjects with pre-diabetes: the DIAPASON study
por: La Sala, Lucia, et al.
Publicado: (2020)

Physiological monitoring of the complex multimorbid heart failure patient – diabetes and monitoring glucose control
por: Seferović, Petar M, et al.
Publicado: (2019)

Clinical implications of the universal definition for the prevention and treatment of heart failure
por: Chandramouli, Chanchal, et al.
Publicado: (2022)

SGLT‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects
por: Lam, Carolyn S. P., et al.
Publicado: (2019)

Teneligliptin enhances the beneficial effects of GLP-1 in endothelial cells exposed to hyperglycemic conditions
por: De Nigris, Valeria, et al.
Publicado: (2017)

Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms
por: Sardu, Celestino, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kefc2er7cs9q9ml4pd579tru9b